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Biomass is widely used for fuel in developing countries. Particles and gases of biomass burning may cause 
changes in the lung. In this prospective study we investigated histopathological changes in the lungs of 
42 non-smoking women [mean age (59±10) years] caused by biomass smoke. We valuated exposure to 
biomass smoke, case histories, and the fi ndings of physical examination, radiology, bronchoscopy, and 
lung histopathology. Mean exposure to biomass smoke was (28±9) hour-year (1 hour-year equals 365 
hours of exposure per year with average exposure of 1 hour a day). The radiological fi ndings were mass 
(42 %), reticulonodular opacities (31 %), mediastinal lymphadenopathy (26 %), pleuro-parenchymal 
fi brotic banding (19 %), widening of the pulmonary artery (14 %), ground glass (11 %), mosaic perfusion 
(9 %), consolidation (9 %), segmental or subsegmental atelectasis (7 %), and bronchiectasis (7 %). The 
patients were diagnosed with lung cancer (35 %), interstitial lung disease (31 %), sarcoidosis (9 %), 
tuberculosis (9 %), chronic obstructive pulmonary disease (4 %), chronic bronchitis (9 %), and metastasis 
(4 %). Bronchoscopy showed pilies, oedema, erythema, bronchus narrowing, endobronchial tumour, 
mucosal irregularity, increased vascularisation, blue-black anthracotic plaques, mucosal oedema, and 
purulent secretion. Transbronchial biopsies revealed neutrophil and lymphocyte leucocytes in the 
perivascular, peribronchiolar, and interalveolar septa, slightly enlarged connective tissue, thickening of 
the basal membrane, thickening of interalveolar septa, intimal and medial thickening of the vascular wall 
and vascular lumen narrowing, anthracosis between the cells and in the bronchiole epithelium. These 
fi ndings confi rm that biomass smoke has important toxic effects on the lung parenchyma, interstitium, and 
pulmonary vessels that may result in malignancies.
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Heat releasing sources composed of biological 
material are called biomass’. Burning biomass and 
poor indoor air exchange may cause chronic lung 
diseases, interstitial lung disease, and cancer. The use 
of biomass in Turkey is common due to social, 
economic, and cultural reasons.
The most important aetiological factor in biomass-
related disease is the pollutant being released (1-3). 
In suburban areas of Turkey women who make fi re, 
bake, and cook with biomass primarily composed of 
cowpat are exposed to its smoke. that may contain 
harmful pollutants such as aldehydes, phenols, and 
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toluene (4, 5). Incomplete burning of animal waste 
also releases CO, NO2, and SO2 (5). Exposure in this 
population, who are poor and have little access to 
healthcare services, is often associated with chronic 
lung damage and respiratory infections.
Our earlier experimental study (6) showed 
histopathological changes in the trachea and the lungs 
of rats exposed to biomass smoke for one hour a day 
for three, six, and nine months. Histopathological 
findings included lymphocyte, eosinophil, and 
macrophage infi ltrations in the interstitium, small 
papillary structures in the airway mucosa, thickening 
of the intimae and media of the pulmonary vessels, 
narrowing of pulmonary vessel lumens, and papillary 
adenomatous proliferation of the mucosa (6).
The aim of this study was to determine if similar 
changes occurred in human lungs after biomass smoke 
exposure. The number of studies which include 
bronchoscopy in people exposed to biomass smoke is 
very small and we hoped to fi ll in this gap by analysing 
histopathological fi ndings in transbronchial tissue 
samples from women who had bronchoscopy 
performed and who were exposed to biomass 
smoke.
MATERIALS AND METHODS
This prospective study was approved by bioethics 
committees of the Yuzuncu Yil University Faculty of 
Medicine, and observed the Declaration of Helsinki. 
It was carried out between January 2007 and 
September 2009 in 42 women who had pathological 
fi ndings on lung roentgenograms. The women were 
exposed to biomass smoke for various hour-years (1 
hour-year equals 365 hours of exposure per year with 
average exposure of 1 hour a day). Biomass exposure 
in the absence of other pollutant exposure is rare in 
men, and we excluded male patients from the study. 
Women who smoked tobacco and were exposed to 
biomass smoke were also excluded from the study. 
All of the patients lived in the countryside, which 
excludes an infl uence of metropolitan atmospheric air 
pollution to a reasonable extent.
Cigarette smoking and biomass exposure were 
determined by interview. The length of exposure to 
biomass smoke was expressed in years and the density 
of exposure in hours per day. Total exposure is 
therefore expressed in hour-years.
Posterior-anterior lung roentgenograms and 
fi ndings of computed tomography (CT) scans were 
analysed to confi rm that the patients met our inclusion 
criteria.
Bronchoscopy was performed in all of the patients 
included in the study according to our diagnostic 
algorithm. All patients signed an informed consent 
form before the procedure. They were also tested for 
platelet count, prothrombin time, and partial 
thromboplastin time. The patients underwent 
bronchoscopy after a four-hour fast and remained in 
the same operation room with resuscitation equipment 
ready throughout the procedure. Those experiencing 
a bronchospasm received a bronchodilator. For local 
anaesthesia they received an 8 mg kg-1 dose of 2 % 
lidocaine solution in spray. The nasal passageway was 
preferred for the use of fiberoptic bronchoscope 
(Olympus, Center Valley, PA, USA). Patients were 
monitored by pulse oximetry. Macroscopic fi nding 
were recorded. Transbronchial biopsy was collected 
from sub-lobe basal segments of patients with 
interstitial changes and common lesions, and from the 
lobes with limited lesions. Three hours after the 
transbronchial biopsy, a posterior-anterior lung 
roentgenogram was taken to exclude pneumothorax. 
Forceps biopsy was performed in patients with 
endobronchial lesions, and transbronchial needle 
aspiration biopsy in patients with mediastinal 
lymphadenopathy. Bacteriological and cytopathological 
analyses were performed on the bronchial lavage and 
biopsy samples. Anthracotic changes, infl ammatory 
infi ltration, thickening at alveolar septum, fi brosis, 
and malignancies were assessed by an experienced 
pathologist. Photos of histopathological samples were 
taken microscopically.
Continuous variables were expressed as mean 
±standard deviation, while categorical variables were 
expressed as number and percentage. To determine 
the difference between the diagnostic groups in terms 
of continuous variables, we used the Mann-Whitney 
U test. To determine the relationships between the 
diagnostic groups and other categorical variables, we 
used the chi-square test and calculated the odds ratio. 
Statistical signifi cance was set at P<0.05. Data were 
processed using the SPSS (version 16) statistical 
software.
RESULTS
The age, biomass exposure, bronchoscopy fi ndings, 
and diagnosis for individual patients are shown in 
Table 1. Average biomass exposure years and total 
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exposure Bronchoscopy fi ndings Diagnosis
36 8.5 11 Normal Chronic bronchitis
59 25.7 35 Narrowing in the orifi ce of apicoposterior segment of the left upper lobe Chronic bronchitis
51 25.7 29 Anthracotic plaque in the orifi ce of right upper lobe Chronic bronchitis
69 38.5 45 Hyperaemia and swelling in the lingular segment of the left upper lobe Chronic bronchitis
63 21.4 30 Normal Chronic bronchitis+ILD
60 34.2 35 Normal Chronic bronchitis+ILD
70 51.4 43 Anthracotic plaque in the orifi ce of right upper lobe, and pale mucosa
Chronic bronchitis 
+ILD
59 34.2 33 Normal COPD+ILD
61 34.2 36 Normal COPD+ILD
51 14.2 30 Mass in the lingular segment of the left upper lobe Oesophageal cancer
43 25.7 15 Normal ILD
69 25.7 41 Mucosal erythema and oedema ILD
54 25.7 32 Normal ILD
65 38.5 40 Widespread anthracosis and swelling in mucosa ILD
77 42.8 50 Normal ILD
69 42.8 37 Widespread anthracotic plaques ILD
63 17.1 31 Indirect tumour fi ndings in left bronchial system ILD+PE
64 17.1 29 Narrowing in the orifi ce of right middle lob Lung cancer
65 17.1 32 Anthracosis and narrowing in the orifi ce of anterior segment of right upper lobe Lung cancer
57 17.1 28 A mass in right middle lobe Lung cancer
58 17.1 35 A mass in right main bronchus Lung cancer
46 21.4 20 A mass in left main bronchus Lung cancer
57 25.7 32 A mass in right main bronchus Lung cancer
71 25.7 50 A mass in the intermediary bronchus Lung cancer
58 30.0 32 A mass in the intermediary bronchus Lung cancer
43 30.0 18 A mass in the intermediary bronchus Lung cancer
55 34.2 31 Narrowing in the orifi ce of right upper lobe Lung cancer
66 34.2 43 A mass in left main bronchus Lung cancer
65 38.5 40 Paralysis of left vocal cord and mass in left main broncus Lung cancer
74 42.8 51 Submucosal swelling and narrowing in the orifi ce of right upper lobe Lung cancer
76 42.8 60 Total obstruction in right lower lobe bronchus Lung cancer
68 42.8 41 Narrowing in the orifi ce of left upper lobe Lung cancer
68 38.5 39 Normal Pancreatic cancer
34 1.1 14 Normal Pneumonia
50 21.4 29 Subcarinal enlargement Sarcoidosis
53 25.7 31 Subcarinal enlargement Sarcoidosis
54 25.7 33 Subcarinal enlargement Sarcoidosis
56 34.2 29 Subcarinal enlargement Sarcoidosis
45 25.7 17 Erythema in the orifi ce of right lower lobe Tuberculosis
59 25.7 40 Normal Tuberculosis
55 30.0 35 Narrowing in the orifi ce of posterior and anterior segments of right upper lobe Tuberculosis
67 34.2 42 Anthracosis and obstruction in the orifi ce of superior segment of right lower lobe Tuberculosis
COPD = chronic obstructive pulmonary disease; ILD = interstitial lung disease; PE = pulmonary embolism 
Gunbatar H, et al. CHRONIC EFFECTS OF ENVIRONMENTAL BIOMASS SMOKE
Arh Hig Rada Toksikol 2012;63:357-365
360
exposure were (13±5) years and (28.6±9.1) hour-
years, respectively. The utilised biomass fuel is called 
tezek, and is produced by dehumidifying animal 
manure. The percent (mean ± SD) of the predicted 
FEV1 and FVC were (90±7) % [(2.6±0.48) L s
-1] and 
(87.8±7.1) % [(2.9±0.44) L s-1], respectively, and the 
FEV1/FVC was (85±6) %. Seven percent of the 
patients had an FEV1/FVC below 70 %.
Radiological fi ndings were as follows: mass (18 
patients, 42.9 %); reticulonodular opacity (13 patients, 
31 %); mediastinal lymphadenopathy (11 patients, 
26.2 %); pleuroparenchymal fibrotic stripes (8 
patients, 19 %); dilatation of the pulmonary artery (6 
patients, 14.3 %); ground glass opacities (5 patients, 
11.9 %); consolidation (4 patients, 9.5 %); mosaic 
perfusion (4 patients, 9.5 %); segmenter or sub-
segmenter atelectasis (3 patients, 7.1 %); and 
bronchiectasis (3 patients, 7.1 %).
Bleeding was seen in only one patient as a 
bronchoscopy complication and was controlled by 
lavage with a solution including adrenalin. 
Pneumothorax was not observed in any of the patients. 
The main fi ndings of bronchoscopy were indirect 
tumour findings such as oedema, erythema, and 
narrowing of the bronchus, indicating acute and 
chronic airway infl ammation. Findings of chronic 
bronchitis included swollen mucosa, purulent sputum, 
and dark blue or black anthracotic plates, generally in 
the upper lung lobes, and especially in the bifurcation 
regions. Direct tumour fi ndings included endobronchial 
neoplasm, mucous instability, and increased blood 
vessels.
We also performed bronchoscopic transbronchial 
biopsy (16 patients, 38 %); mucous biopsy (16 
patients, 38 %); transcarinal needle aspiration biopsy 
(4 patients, 9.5 %); and bronchial lavage (6 patients, 
14 %). Most of the patients had lung cancer and 
interstitial lung disease. Lung disease in these patients 
was diagnosed after more than 27 hours per year of 
biomass smoke exposure. However, one patient with 
11 hours per year of biomass smoke exposure had a 
normal biopsy fi nding. The incision was performed to 
fi nd the cause of haemoptysis.
There was a highly negative correlation between 
interstitial lung disease and lung cancer (P=0.001). 
That biomass smoke exposure may cause different 
diseases in different people may partially be explained 
by a person’s genetic predisposition to a disease.
Table 2 shows the histopathological fi ndings in the 
patients with interstitial lung disease (ILD). Biopsy 
tissue of four patients was lost during examination. 
Transbronchial biopsy taken from 16 of 21 patients 
who were thought to have ILD. Bronchial lavage was 
performed on five patients. Cytological analysis 
showed no malignant cells in these patients. Neutrophils 
were the dominant cell type for many patients. In one 
patient, lymphocytes accounted for 70 % of the cells. 
Tissue samples stained with haematoxylin and eosin 
(H&E) were examined under a light microscope 
(Olympus BX50F–3, Olympus Optical Co., Japan) at 
either 100x or 200x magnifi cation. Figure 1 shows the 
typical tissue samples obtained by bronchoscopy.
In the interalveolar septum, we observed 
perivascular and peribronchial neutrophils, 
lymphocytes, and alveolar macrophage infi ltration. In 
some cases this cell infi ltration let to the thickening 
of the interalveolar septa. In some patients, white 
blood cells infi ltrated the spaces around vessels, the 
intima and the media of the vessels thickened, and 
their lumens narrowed. Black coal dust in the form of 
granular debris or little piles were scattered between 
the cells. Similar piles were found in the bronchioles 
on the apical surface of the epithelium and in the 
intracytoplasmic space. In one patient, nodular fi brotic 
thickening was observed in some places. Bilateral and 
many nodular lesions, more obvious in the sub-lobes, 
were detected by lung tomography in one patient, who 
Figure 1  Histology of representative tissue samples obtained 
by bronchoscopy. The following tissue samples are 
shown with H&E staining at 100x magnifi cation 
except where noted otherwise: (A) Anthracosis in the 
lung parenchyma with vascular wall thickening; (B) 
Basal membrane thickening, eosinophilic 
enhancement in bronchial mucosa (200x); (C) 
Infl ammatory focal thickening of alveolar septipara 
and lung parenchyma; (D) Dominated by lymphocytes, 
few neutrophils and plasma cells showing signs of 
chronic infl ammation of the bronchial mucosa
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was thought to have ILD, but the bronchoscopic lavage 
histopathology did not support this diagnosis. 
However, a bulk was detected at the head of the 
pancreas in an abdomen tomography during 
examination of the patient, and the lung lesions were 
interpreted as metastasis.
Computer tomography detected a mass indicative 
of lung cancer in 14 patients, who then underwent 
bronchoscopy to confi rm or rule out this preliminary 
diagnosis. The following histopathological types of 
lung cancer were detected: small cell in six patients, 
squamous cell in two patients, adenocarcinoma in two 
patients, and bronchoalveolar carcinoma in one 
patient. In two patients, the malignant epithelial 
tumour could not be determined by the cell type, and 
the tumour in one patient was evaluated as benign.
Chronic infl ammation in a patient who complained 
of difficulty swallowing was followed up by 
endoscopy. Transbronchial biopsy revealed esophageal 
squamous carcinoma.
One of the four patients with mediastinal 
lymphadenopathy had right hilar lymphadenopathy 
and one had a consolidation at the right-mid lobe. The 
smear obtained by transcarinal thin needle aspiration 
biopsy did not show malignant cells. Patients 
diagnosed with sarcoidosis were introduced steroid 
treatment. All patients with lymphadenopathy showed 
a degree of regression due to treatment.
Tuberculosis was diagnosed in four patients. 
Mediastinal lymphadenopathy was established in one; 
a consolidation in the sub-lobe superior segment of 
the right lung in another; a consolidation in the sub-
lobe of the right lung together with mediastinal 
lymphadenopathy in one patient; and a consolidation 
with fusion fi elds in the upper lobe of the right lung 
in one patient. Histopathological analysis showed a 
negative fi nding in the fi rst patient, an active chronic 
infl ammation in the second, chronic infl ammation in 
the third, and anthracosis in the fourth. Tuberculosis 
culture of bronchial lavage tested positive and all four 
patients were started antituberculosis treatment.
DISCUSSION
Exposure to biomass in buildings without proper 
ventilation increases the risk of acute airway infections 
in children and COPD, ILD, and lung cancer in the 
adults (2 ,3 ,7 ,8). In Turkey, biomass smoke exposure 
is an important risk factor for lung diseases in non-
smoking women, especially in rural areas. However, 
tobacco smoke and biomass smoke-related lung 
diseases have similar characteristics.
Biomass smoke contains carbon monoxide, nitric 
acid, sulphur oxides, formaldehyde, polycyclic organic 
substances, carcinogens like benzopyrene, and 
particles smaller than 10 micrometers (9). Most of 
these components are mutagenic in vitro (9). Smoke 
is an irritant toxic to cilia and contains coagulant 
agents which affect the respiratory system defence 
and increase the risk of chronic lung infection (10, 
11). Domestically-acquired particulate lung disease 
(DAPLD) is a term used to identify biomass-related 
lung diseases (12). DAPLD manifests itself in a broad 
range of disorders from chronic bronchitis and COPD 
to advanced interstitial lung disease and malignancy.
Studies around the world have established a 
relationship between lung disease and exposure to 
biomass smoke. Pandey et al. (13) have shown that 
COPD prevalence rises with age and is greater 
Nepalese men than women (13). Akhtar et al. (9) 
identifi ed chronic bronchitis in 100 of 1426 Pakistani 
women burning biomass and established a strong 
relationship between bronchitis and biomass use 
compared to a control group. Demirtaş et al. (2) found 
that women who exposed to biomass smoke were 
signifi cantly more prone to COPD than unexposed 
women. Özbay et al. (1) detected a severe obstruction 
and an increase in the lung volume in pulmonary 
function tests of biomass-exposed women. They 
observed radiologically diffuse emphysema, thickening 
at interlobular septa, focal emphysematosa fi elds, and 
an increase in bronchovascular arborisation. They 
showed that biomass smoke increased obstructive and 
restrictive effects on the pulmonary function and 
structure. Our results seem to confirm the above 
studies, especially in reference to COPD. Sandaval et 
al. (14) have suggested that dense anthracotic staining 
is more characteristic of women exposed to biomass 
than of heavy tobacco smokers. Chung et al. (15) 
found anthracotic staining in people exposed to 
biomass smoke, in heavy smokers, miners, and city 
population. Bruce et al. (16) found that tuberculosis 
prevalence was higher in homes using biomass than 
in homes using cleaner combustibles. Similarly, Perez 
Podilla et al. (17) support the fi nding that heating with 
biomass at home contributes to tuberculosis. Shprykov 
et al. (18) found that tobacco smoke had a great effect 
on the structure of Mycobacterium tuberculosis. These 
structural changes suggest that smoke supports 
bacterial growth. In our study, in the four pulmonary 
tuberculosis diagnosed cases, dark anthracotic 
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pigmentation and chronic infl ammation were detected 
that may have contributed to bacterial growth.
Biomass smoke contains numerous chemicals that 
are known or suspected human carcinogens. Mutations 
in human cancer are the most frequent in the p53 gene 
(19). Mutation in the p53 gene is found in 50 % of 
non-small cell lung cancers and in 90 % of small cell 
lung cancers (20).
Cigarette smoke contains almost 60 carcinogenic 
components including benz(a)pyrene (BaP) and 
nicotine-derived nitrosamine ketone (NNK), which 
induce p53 gene mutations (21). Wood smoke contains 
BaP, just like cigarette smoke (16). Delgado et al. (3) 
detected mutation in the p53 gene in lung cancer cases 
related to wood smoke and in cancers caused by 
cigarette smoke. They proposed that, just like cigarette 
smoke, wood smoke can play a role in lung cancer. 
Malatz et al. (22) found higher frequency of genetic 
polymorphism in glutathione S-transferase enzymes 
in non-smoking lung cancer patients who were 
exposed to wood smoke for more than 20 years. In the 
regions of China in which lung cancer is common in 
humans, Liang et al. (23) investigated exposure to coal 
and wood smoke in mice and rats and found that wood 
smoke exposure involved a higher risk of cancer than 
control, but a lower risk compared to coal smoke 
exposed animals. Consistent with all these studies, our 
study has shown that biomass smoke exposure is an 
important risk factor for human lung cancer 
According to Gold et al. (24), cooking may produce 
high levels of BaP that equal a packs of cigarettes a 
day. In another study (16), BaP levels detected over 
three hours of cooking a day equalled two packs of 
cigarettes a day. These analogies help to explain how 
biomass smoke exposure can contribute to the growth 
of malignancy. Behera et al. (25) showed that 
adenocarcinoma was the dominant histopathological 
type of lung cancer in non-smoking women exposed 
to wood smoke. Similarly in Delgado et al. (3), the 
main histopathological type was adenosarcoma in 
patients exposed to wood smoke (3). Hoffman et al. 
(26) showed that nicotine-derived nitrosamine ketone 
(NNK), contributed to adenocarcinoma and BaP to 
squamous cell carcinoma in lab animals. It is thought 
that wood smoke, like cigarette smoke, contains BaP, 
but it may also contain NNK and other carcinogens. 
In our patients, small cell carcinoma was the primary 
type of lung cancer, possibly due to a specific 
composition of the biomass.
Kajdaz et al. (27) found a signifi cant correlation 
between wood smoke exposure and sarcoidosis. In 
another study (28) wood burning and organic dust 
exposure had a signifi cantly higher correlation with 
sarcoidosis. In our study, four patients were diagnosed 
with sarcoidosis. 
Chronic biomass smoke exposure changes the 
defense mechanisms of the lung mucociliary system 
and decreases the antibacterial capacity of macrophage 
(15, 29). It may cause bronchial narrowing or blockage 
due to anthracosis or mucoid secretion piles at distal 
lung fields, and development of pneumonia at 
segments or lobes. Repeating infections increase 
bronchiectasis. Consistent with our study, Kara et al. 
(30) concluded that biomass smoke caused many 
diseases, from chronic bronchitis to interstitial lung 
disease.
Like in some of our patients, a transbronchial 
biopsy conducted in a patient exposed to wood smoke 
in India showed the existence of coal macules (31). 
The main pathological changes in the transbronchial 
tissue samples of patients exposed to inorganic dust 
were similar to other interstitial lung diseases (32-34). 
The samples showed focal thickening of the alveolar 
septum and a mix of infl ammatory infi ltration, fi brosis 
and basal membrane thickening. Restrepo et al. (35) 
found similar pathological fi brotis changes in animals 
and patients exposed to wood smoke for a long time. 
Ramage et al. (36) identifi ed a similar relationship 
between interstitial lung disease and wood smoke 
exposure.
Table 2 Histopathological features of patients (N=11) with interstitial lung disease
Histopathology Feature Patients with feature n (%)
Anthracotic pigment 7 (63)
Basal membrane thickening 6 (54)
Alveolar septal thickening 2 (18)
Goblet cell metaplasia 2 (18)
Fibrosis 1 (9)
Squamous metaplasia 0
Chronic infl ammation 11 (100)
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Our study has showed that exposure to biomass 
can cause histopathological lung lesions that range 
from the upper airway infl ammation to interstitial 
fibrosis and malignancy. These histopathological 
changes provide evidence of specific diseases 
attributable to biomass smoke exposure in non-
smoking women. One of the limitations of our study 
is that we have not established whether the exposed 
women were also exposed to secondary tobacco 
smoke.
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Sažetak
KRONIČNI UČINCI AMBIJENTALNOGA DIMA IZ BIOMASE NA HISTOPATOLOGIJU PLUĆA U 
LJUDI: OPIS NIZA SLUČAJEVA
Biomasa se u mnogim zemljama u razvoju rabi za gorivo. Čestice i plinovi izgorene biomase mogu dovesti 
do plućnih promjena. Ovdje smo istražili histološke promjene u plućima ljudi uzrokovane biomasom. Ovo 
je prospektivno ispitivanje obuhvatilo 42 nepušačice izložene dimu iz biomase u kojih je ocijenjena 
izloženost dimu, uzeta povijest bolesti, napravljen fi zikalni pregled te analizirani radiološki, bronhoskopski 
i histopatološki nalazi. Srednja dob ispitanica bila je (59±10) godina. Srednja izloženost dimu iz biomase 
iznosila je (28±9) sati na godinu. Radiološki nalazi upozorili su na tumorsku tvorbu (u njih 42 %), 
retikulonodularna zasjenjenja (31 %), limfadenopatiju medijastinuma (26 %), fi brozne promjene pleure i 
plućnog parenhima (19 %), proširenje plućne arterije (14 %), sliku smrvljenog stakla (11 %), sliku mozaične 
perfuzije (9 %), konsolidacije (9 %), segmentnu i subsegmentnu atelektazu (7 %) te bronhijektazije (7 %). 
U njih 35 % dijagnosticiran je rak pluća, u 31 % bolesti plućnog intersticija, u 9 % sarkoidoza, u 9 % 
tuberkuloza, u 4 % KOPB, u 9 % kronični bronhitis te u 4 % metastaze. Bronhoskopija je pokazala pilije, 
edem, eritem, sužavanje bronhija, endobronhijalni tumor, neurednu sluznicu, izrazitiju vaskularizaciju, 
plavo-crne antrakotične plakove, otjecanje sluznice te purulentnu sekreciju. Transbronhijalnom biopsijom 
pronađeni su neutrofi li i limfociti u perivaskularnom, peribronhiolarnom tkivu i interalveolarnim septumima, 
zadebljanje vezivnoga tkiva, zadebljanje bazalne membrane, zadebljanje interalveolarnih septuma, 
zadebljanja stijenke žila intimalno i medijalno te suženje njihova lumena, crna antrakoza između stanica 
te u epitelu bronhiola. Sve to upozorava na značajne promjene uzrokovane biomasom, koje obuhvaćaju 
zloćudne formacije uslijed toksičnoga djelovanja na plućni parenhim, intersticij i žile.
KLJUČNE RIJEČI: izloženost dimu biomase, plućne bolesti
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